Mylan (MYL) Receives Approval for Generic Zyvox Jul 3, 2008 08:04AM

Mylan Inc. (NYSE: MYL) announced that its subsidiary, Mylan Pharmaceuticals Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Linezolid Tablets, 600 mg.

Linezolid Tablets, an antibiotic, are the generic version of Pharmacia and Upjohn's Zyvox(R) Tablets, which had U.S. sales of approximately $422 million for the 12 months ending March 31, 2008, according to IMS Health.[SM]


APP Pharmaceuticals (APPX) Receives Final Approval for Generic Kytril Jul 3, 2008 08:04AM

APP Pharmaceuticals, Inc. (Nasdaq: APPX) received final approvals from the FDA of its Abbreviated New Drug Applications (ANDAs) for Granisetron Hydrochloride Injection, 1 mg/mL, 1 mL single dose, and 1mg/mL, 4mL multiple dose vials, the generic equivalent of Hoffmann-LaRoche's Kytril Injection.


Mylan (MYL) Receives Tentative Approval for Generic Zyvox Jul 3, 2008 08:03AM

Mylan Inc. (NYSE: MYL) received tentative approval from the FDA for its Abbreviated New Drug Application for Linezolid Tablets, 600 mg.

Linezolid Tablets, an antibiotic, are the generic version of Pharmacia and Upjohn's Zyvox(R) Tablets, which had U.S. sales of approximately $422 million for the 12 months ending March 31, 2008, according to IMS Health.


Adolor (ADLR) Provides Update on Entereg(R) (alvimopan) OBD Program Jul 3, 2008 07:47AM

Adolor Corporation (Nasdaq: ADLR) issued an update on the Entereg(R) (alvimopan) Program for chronic opioid bowel dysfunction (OBD), under development in collaboration with GlaxoSmithKline (NYSE: GSK).

The U. S. Food and Drug Administration (FDA) has concluded that clinical investigations relating to alvimopan in OBD may now proceed, and has therefore lifted the clinical hold on the OBD Investigational New Drug Application.


SkyePharma PLC (SKYE) Announces Positive Phase III Data on FlutiformTM Jul 3, 2008 07:09AM

SkyePharma PLC (Nasdaq: SKYE) announces that its third Phase III efficacy study evaluating FlutiformTM for the treatment of mild to moderate asthma in adolescent and adult patients has met its primary endpoints.


More FDA

View Older Stories

Jul 3, 2008 07:05AM Chindex (CHDX) Receives Key China Approvals
Jul 2, 2008 05:29PM Boston Scientific (BSX) Receives FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System
Jul 2, 2008 04:24PM FDA Approves Abbott's (ABT) Drug Coated Stent, XIENCE
Jul 2, 2008 04:20PM ARYx (ARYX) Announces Successful Study Results But Procter & Gamble (PG) Ends Collaboration
Jul 2, 2008 09:06AM Hansen Medical (HNSN) Announces FDA Clearance for CoHesion(TM) Module
Jul 2, 2008 06:55AM Bayer HealthCare and Maxygen (MAXY) Enter Hematology Agreement
Jul 1, 2008 04:23PM Teva Pharmaceutical (TEVA) Updates Court Ruling to Market Generic Seroquel
Jul 1, 2008 09:05AM SenoRx (SENO) Announces FDA 510(k) Clearance for Contura MLB
Jul 1, 2008 06:37AM EPIX Pharm (EPIX) Resubmits NDA For Vasovist
Jun 30, 2008 05:56PM Alpharma (ALO) Resubmits New Drug Application for EMBEDA(TM) Capsules
Jun 30, 2008 05:39PM Janssen Announces Launch of Authorized Generic for RISPERDAL(R) Through Patriot Pharma (JNJ)
Jun 30, 2008 03:40PM Teva Pharmaceutical (TEVA) Receives FDA Approval for Generic Risperdal
Jun 30, 2008 02:22PM Par Pharmaceutical (PRX) Receives FDA Approval for Generic Marinol
Jun 30, 2008 10:30AM Indevus (IDEV) Receives Approvable Letter for NEBIDO Expressing Concerns; Co Revises Operating Plan
Jun 30, 2008 08:05AM Pfizer (PFE) Announces FDA Approves Convenia for Dogs and Cats
Jun 30, 2008 08:03AM Acura Pharmaceuticals (ACUR) Announces $5M Milestone Payment
Jun 30, 2008 07:58AM Myriad Genetics (MYGN) Sinks After Flurizan Fails In Phase 3 Alzheimer's Trial
Jun 30, 2008 07:38AM Labopharm (DDSS) Receives Response From FDA After Appeal of 'Approvable Letter'
Jun 30, 2008 07:32AM Hana Biosciences (HNAB) Receives US Oprhan Drug Status for Marqibo
Jun 27, 2008 08:27AM Schering-Plough (SGP) and Merck (MRK) Announce Withdrawal of NDA for Loratadine/Montelukast Combination Tablet
Jun 26, 2008 05:28PM Barr Pharma (BRL) Announces Favorable Ruling in Mirapex Patent Challenge
Jun 26, 2008 09:03AM Akorn-Strides, LLC (AKRX) Announces FDA Approvals for Famotidine Injection USP
Jun 26, 2008 07:47AM Vanda (VNDA) Said Tasimelteon Significantly Improves Sleep in Patients with Chronic Insomnia
Jun 25, 2008 08:59AM FDA Issues Response Letter Regarding Mercks (MRK) Use of GARDASIL in Women 27 to 45
Jun 25, 2008 08:10AM SurModics (SRDX) Announces $9M Milestone Payment After Trial Initiates by Merck
Jun 25, 2008 07:05AM Osiris Therapeutics (OSIR) Announces $2M Milestone Payment
Jun 23, 2008 08:53AM Emisphere Techn (EMIS) In License Agreement With Novo Nordisk
Jun 23, 2008 08:33AM Warner Chilcott (WCRX) Announces FDA Aproval of RYX Delayed-Release 150 mg Tablets
Jun 23, 2008 08:08AM FDA Licenses Sanofi Pasteur's Pediatric Combination Vaccine, Pentacel
Jun 20, 2008 04:03PM Ligand Pharmaceuticals (LGND) Partner GlaxoSmithKline (GSK) Receives FDA Extended Priority Review for PROMACTA(R) NDA
Jun 20, 2008 08:50AM Merck (MRK) Updates Regulatory Status on MK-0524A and MK-0524B
Jun 20, 2008 07:01AM GlaxoSmithKline (GSK) Announces FDA Approval for AVODART w/Tamsulosin for Enlarged Prostate
Jun 19, 2008 09:04AM ThermoGenesis (KOOL) Receives of CE Mark for MarrowXpress
Jun 19, 2008 08:59AM Perrigo (PRGO) Announces Approval for Rx Cetirizine Syrup
Jun 19, 2008 08:43AM Discovery Labs (DSCO) Receives Clarification from FDA on Limited Items in SURFAXIN Approvable Letter
Jun 19, 2008 08:36AM AVANIR (AVNR) Announces Grant of New Zenvia Patent
Jun 18, 2008 04:11PM Eurand (EURX) Receives Approvable Letter From FDA for EUR-1008 (Zentase)
Jun 18, 2008 08:07AM China Sky One Medical (CSY) Obtains SFDA Approval to Produce Four New Drugs
Jun 17, 2008 02:26PM FDA Panel Says Johnson & Johnson (JNJ) Data Proves That New Psoriasis Drug Works -Bloomberg
Jun 17, 2008 08:32AM Genzyme (GENZ) Submits U.S. and European Applications for Approval of Mozobil
Jun 17, 2008 08:12AM Oculus Innovative Sciences (OCLS) Announces Development of a Microcyn Hydrogel Formulation
Jun 17, 2008 07:32AM Allergan (AGN) Receives FDA Approval for TRIVARIS(TM) 80/mg/mL
Jun 16, 2008 06:26PM NPS Pharmaceuticals (NPSP) Receives FDA Letter Related to Generic Version of Company's Sensipar
Jun 16, 2008 02:25PM Mylan (MYL) Pharmaceuticals Receives Final FDA Approval for Generic Effexor(R) and Tenative FDA Approval for Generic Version of Avalide(R)
Jun 16, 2008 09:49AM AVI BioPharma (AVII) Partner Receives European Approval for a New Cobalt Chromium Bare Metal Stent
Jun 16, 2008 08:09AM Eli Lilly (LLY) Announces FDA Approval of Cymbalta for Fibromyalgia
Jun 16, 2008 07:42AM ACADIA (ACAD) Said ACP-104 Fails In Trials
Jun 16, 2008 07:40AM Teva Pham (TEVA) Said AZILECT Successfully Meet End Points
Jun 12, 2008 12:52PM Mindray Medical (MR) Announces FDA 510(k) Clearance for AS3000 Anesthesia Delivery System
Jun 12, 2008 11:14AM Teva Pharmaceutical (TEVA) Receives Tentative FDA Approval for Generic Diovan
View Older Stories